Skip to main content
. 2018 Jun 14;193(2):178–182. doi: 10.1111/cei.13136

Figure 1.

Figure 1

Prevalence of anti‐nuclear antibodies (ANA) in patients with breast tumours and controls. *Malignant versus benign: odds ratio (OR) = 4·26; 95% confidence interval (CI) = 1·14–15·92. **Malignant versus controls: OR = 13·76; 95% CI = 4·98–37·95.